A detailed history of Benjamin Edwards Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 7,565 shares of ZTS stock, worth $1.32 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,565
Previous 179 4126.26%
Holding current value
$1.32 Million
Previous $35,000 3557.14%
% of portfolio
0.25%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$165.67 - $199.94 $1.22 Million - $1.48 Million
7,386 Added 4126.26%
7,565 $1.28 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $605 - $800
4 Added 2.29%
179 $35,000
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $8,524 - $9,831
51 Added 41.13%
175 $30,000
Q2 2023

Aug 15, 2023

SELL
$160.94 - $186.23 $804 - $931
-5 Reduced 3.88%
124 $21,000
Q1 2023

Apr 27, 2023

BUY
$145.48 - $175.02 $18,766 - $22,577
129 New
129 $21,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.